# Alexander J. Lazar

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alexander-j-lazar/

## Facts

| Field | Value |
| --- | --- |
| Citations | 131,706 |
| Field | Sarcoma Diagnosis and Treatment |
| h-index | 150 |
| i10-index | 548 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5050445982 |
| ORCID iD | https://orcid.org/0000-0002-6395-4499 |
| Works | 1,545 |

## Researcher papers

Showing 12 of 18.

- [An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics](https://scholariq.org/papers/an-integrated-tcga-pan-cancer-clinical-data-resource-to-drive-high-quality/)
- [Oncogenic Signaling Pathways in The Cancer Genome Atlas](https://scholariq.org/papers/oncogenic-signaling-pathways-in-the-cancer-genome-atlas/)
- [Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer](https://scholariq.org/papers/cell-of-origin-patterns-dominate-the-molecular-classification-of-10-000-tumors/)
- [B cells and tertiary lymphoid structures promote immunotherapy response](https://scholariq.org/papers/b-cells-and-tertiary-lymphoid-structures-promote-immunotherapy-response/)
- [Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation](https://scholariq.org/papers/machine-learning-identifies-stemness-features-associated-with-oncogenic/)
- [Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy](https://scholariq.org/papers/loss-of-pten-promotes-resistance-to-t-cell-mediated-immunotherapy/)
- [Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial](https://scholariq.org/papers/pembrolizumab-in-advanced-soft-tissue-sarcoma-and-bone-sarcoma-sarc028-a/)
- [Genomic and Functional Approaches to Understanding Cancer Aneuploidy](https://scholariq.org/papers/genomic-and-functional-approaches-to-understanding-cancer-aneuploidy/)
- [The 2019 World Health Organization classification of tumours of the breast](https://scholariq.org/papers/the-2019-world-health-organization-classification-of-tumours-of-the-breast/)
- [Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review](https://scholariq.org/papers/circulating-tumor-dna-analysis-in-patients-with-cancer-american-society-of/)
- [Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma](https://scholariq.org/papers/neoadjuvant-immune-checkpoint-blockade-in-high-risk-resectable-melanoma/)
- [Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance](https://scholariq.org/papers/pan-cancer-t-cell-atlas-links-a-cellular-stress-response-state-to-immunotherapy/)

## Researcher topics

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.